118 STAT. 255 PUBLIC LAW 108–199—JAN. 23, 2004 infectious diseases, chronic and environmental diseases, and other health activities abroad. SEC. 216. The Division of Federal Occupational Health may utilize personal services contracting to employ professional manage ment/administrative and occupational health professionals. SEC. 217. Notwithstanding section 409B(c) of the Public Health Service Act regarding a limitation on the number of such grants, funds appropriated in this Act and Acts in fiscal years thereafter may be expended by the Director of the National Institutes of Health to award Core Center Grants to encourage the development of innovative multidisciplinary research and provide training con cerning Parkinson’s disease. Each center funded under such grants shall be designated as a Morris K. Udall Center for Research on Parkinson’s Disease. SEC. 218. Not later than 90 days after the date of enactment of this Act, the Director of the National Institutes of Health shall submit to the appropriate committees of Congress a report that shall— (1) contain the recommendations of the Director concerning the role of the National Institutes of Health in promoting the affordability of inventions and products developed with Federal funds; and (2) specify whether any circumstances exist to prevent the Director from promoting the affordability of inventions and products developed with Federal funds. SEC. 219. Notwithstanding any other provisions of law, funds made available under this heading may be used to continue oper ating the Council on Graduate Medical Education established by section 301 of Public Law 102–408. SEC. 220. DESIGNATION OF SENATOR PAUL D. WELLSTONE NIH MDCRC PROGRAM. (a) FINDINGS.—Congress finds the following: (1) On December 18, 2001, Public Law 107–84, otherwise known as the Muscular Dystrophy Community Assistance, Research and Education Amendments of 2001, or the MD CARE Act, was signed into law to provide for research and education with respect to various forms of muscular dystrophy, including Duchenne, Becker, limb girdle, congenital, facioscapulohumeral, myotonic, oculopharyngeal, distal, and EmeryDreifuss muscular dystrophies. (2) In response to the MD CARE Act of 2001, in September 2002, the National Institutes of Health (NIH) announced its intention to establish the Muscular Dystrophy Cooperative Research Centers (MDCRC) program. (3) Senator Paul D. Wellstone was a driving force behind enactment of the MD CARE Act, which led to the establishment of the MDCRC program. (b) DESIGNATION.—The NIH Muscular Dystrophy Cooperative Research Centers (MDCRC) program shall be known and designated as the ‘‘Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers’’, in honor of Senator Paul D. Wellstone who was deceased on October 25, 2002. (c) REFERENCES.—Any reference in a law, regulation, document, paper, or other record of the United States to the NIH program of Muscular Dystrophy Cooperative Research Centers shall be deemed to be a reference to the ‘‘Senator Paul D. Wellstone Mus cular Dystrophy Cooperative Research Centers’’. 42 USC 294o note. Deadline. Reports. 42 USC 284f note.